N-[1-(Tosyl-1H-indol-2-yl)-2-propyl]formamide (2). A mixture of compound 1 (5 g, 15 mmol) in
formamide (100 ml) was refluxed for 40 min (TLC monitoring). The reaction mixture was poured into water (1
litre). The precipitate formed was filtered off and recrystallized from a mixture of dichloromethane and hexane.
Yield 4 g (75%) as a white powder. The compound obtained was used in the subsequent stage without further
purification.
3-Methyl-5-tosyl-5H-pyrido[4,3-b]indole (4). A mixture of compound 2 (2 g, 5.6 mmol) in ethyl
polyphosphate (Et-PPA) (40 ml) was refluxed for 4 h (TLC monitoring). The reaction mixture was poured into
water (300 ml), neutralized with NaHCO3, and extracted with ethyl acetate (3×50 ml). The extract was dried
over Na2SO4, filtered, treated with carbon, and the solvent was removed in vacuo. DDQ (0.2 g) was added and
the product was refluxed for 5-7 min (TLC monitoring). The reaction mixture was then poured into water
(100 ml) and extracted with ethyl acetate (3×30 ml). Solvent was removed in vacuo and the residue was column
chromatographed using benzene–hexane (1:3). Yield 0.72 g (38%) as a light-cream powder; mp 173-174ºC
1
(mixture of benzene and hexane). IR spectrum, ν, cm-1: 1596, 1456, 1366, 1175, 1153, 980, 708. H NMR
spectrum, δ, ppm (J, Hz): 2.27 (3H, s, CH3); 2.74 (3H, s, CH3); 7.14 (2H, d, J = 8.1, H Ts); 7.34-7.39 (1H, m,
H Ar); 7.46-7.52 (1H, m, H Ar); 7.73 (2H, d, J = 8.1, H Ts); 7.92-7.94 (1H, m, H Ar); 8.05 (1H, s, H Py);
8.23-8.26 (1H, m, H Ar); 9.05 (1H, s, Py). 13C NMR spectrum, δ, ppm: 21.5, 25.1, 108.4, 114.7, 120.0, 120.1,
124.0, 124.4, 126.5 (2C); 127.8, 129.9 (2C); 134.7, 137.9, 141.8, 144.3, 145.5, 156.5. Found, %: C 67.98;
H 4.57; N 8.12. C19H16N2O2S. Calculated, %: C 67.84; H 4.79; N 8.33.
This work was carried out with the financial support of the Russian Fund for Basic Research (grant
07-03-00352-a), the Ministry of Education and Science, Russian Federation (project No. 2.1.1/4628 RNPVSh)
and the Bayer HealthCare AG Company (Germany).
REFERENCES
1.
V. I. Dulenko, I. V. Komissarov, A. T. Dolzhenko, and Yu. A. Nikolyukin, β-Carbolines. Chemistry
and Neurobiology [in Russian], Naukova Dumka, Kiev (1992).
2.
3.
P. A. S. Smith and J. H. Boyer, J. Amer. Chem. Soc., 73, 2626 (1951).
M. Abou-Gharbia, U. R. Patel, M. B. Webb, J. A. Moyer, T. H. Andree, and E. A. Muth, J. Med. Chem.,
30, 1818 (1987).
4.
C. A. Harbert, J. J. Plattner, W. M. Welch, A. Weissman, and B. K. Koe, Mol. Pharmacol., 17, 38
(1980).
5.
6.
C.-S. Lee, T. Ohta, K. Shudo, and T. Okamoto, Heterocycles, 16, 1081 (1981).
J. H. Wynne and W. M. Stalick, J. Org. Chem., 68, 4854 (2003).
7.
8.
T. Iwaki, A. Yasuhara, and T. Samamoto, J. Chem. Soc., Perkin Trans. 1, 1505 (1999).
H. Zhang and R. C. Larock, Org. Lett., 3, 3083 (2001).
9.
10.
M. Somei, F.Yamada, and G. Yamamura, Chem. Pharm. Bull., 46, 191 (1988).
N. N. Novikova, I. D. Silenko, N. F. Kucherova, and V. A. Zagorevskii, Khim. Geterotsikl. Soedin.,
1630 (1976). [Chem. Heterocycl. Comp., 12, 1340 (1976)].
11.
12.
H. Akimoto, A. Kawai, H. Nomura, M. Nagao, T. Kawachi, and T. Sugimura, Chem. Lett., 1061 (1977).
A. V. Butin, Tetrahedron Lett., 47, 4113 (2006).
614